Registration, publication, and outcome reporting among pivotal clinical trials that supported FDA approval of high-risk cardiovascular devices before and after FDAAA
Abstract Background Selective registration, publication, and outcome reporting of clinical trials distort the primary clinical evidence that is available to patients and clinicians regarding the safety and efficacy of US Food and Drug Administration (FDA)-approved medical devices. The purpose of thi...
Guardado en:
Autores principales: | Matthew J. Swanson, James L. Johnston, Joseph S. Ross |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
BMC
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/71c1373a0d574587b16ff51186dbd5f8 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Medical device regulations global overview and guiding principles /
por: Cheng, Michael
Publicado: (2003) -
Methodological Characteristics of Clinical Trials Supporting the Marketing Authorisation of Advanced Therapies in the European Union
por: Carolina Iglesias-Lopez, et al.
Publicado: (2021) -
Current landscape of clinical development and approval of advanced therapies
por: Carolina Iglesias-Lopez, et al.
Publicado: (2021) -
New frontiers in oncolytic viruses: optimizing and selecting for virus strains with improved efficacy
por: Lundstrom K
Publicado: (2018) -
One-Night Stands and Long-Term Commitments: Presidential Approval for Sebastián Piñera in Chile, 2009-2014
por: Navia,Patricio, et al.
Publicado: (2019)